Electra Therapeutics Overview
- Year Founded
-
2018
- Status
-
Public
- Employees
-
46
- Stock Symbol
-
ETRA
- Share Price
-
$8.84
- (As of Friday Closing)
Electra Therapeutics General Information
Description
Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. The company's pipeline includes Ipsoprubart and ELA822.
Contact Information
Website
www.electra-therapeutics.comCorporate Office
- 230 East Grand Avenue
- Suite S-100
- South San Francisco, CA 94080
- United States
Corporate Office
- 230 East Grand Avenue
- Suite S-100
- South San Francisco, CA 94080
- United States
Electra Therapeutics Stock Performance
As of 13-Nov-2026, Electra Therapeutics’s stock price is $8.84. Its current market cap is $555M with 62.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $8.84 | $9.11 | $6.87 - $15.50 | $555M | 62.8M | 583K | -$2.65 |
Electra Therapeutics Financials Summary
As of 30-Jun-2026, Electra Therapeutics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| EBITDA | (86,582) | (61,843) | (26,310) |
| Net Income | (85,526) | (61,975) | (24,786) |
| Total Assets | 106,498 | 99,368 | 19,420 |
| Total Debt | 1,983 | 2,087 | 0 |
Electra Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Electra Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Electra Therapeutics Comparisons
Industry
Financing
Details
Electra Therapeutics Competitors (80)
One of Electra Therapeutics’s 80 competitors is Immunocore Holdings, a Formerly VC-backed company based in Abingdon, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immunocore Holdings | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Fate Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Exicure | Formerly VC-backed | Chicago, IL | ||||
| Lite Strategy | Corporation | San Diego, CA |
Electra Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Electra Therapeutics Patents
Electra Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026181020-A1 | Sirp gamma antibodies for treatment of granulomatous diseases and disorders | Pending | 28-Feb-2025 | ||
| WO-2025226691-A1 | Sirp alpha and beta antibodies for treatment of epstein–barr virus infections | Pending | 22-Apr-2024 | ||
| AU-2025260136-A1 | Sirp alpha, beta, gamma antibodies for treatment of epstein–barr virus infections | Pending | 22-Apr-2024 | ||
| WO-2025226685-A1 | Sirp alpha, beta, gamma antibodies for treatment of epstein–barr virus infections | Pending | 22-Apr-2024 | ||
| WO-2025226693-A1 | Sirp gamma antibodies for treatment of epstein–barr virus infections | Pending | 22-Apr-2024 | C07K16/2803 |
Electra Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Electra Therapeutics FAQs
-
When was Electra Therapeutics founded?
Electra Therapeutics was founded in 2018.
-
Where is Electra Therapeutics headquartered?
Electra Therapeutics is headquartered in South San Francisco, CA.
-
What is the size of Electra Therapeutics?
Electra Therapeutics has 46 total employees.
-
What industry is Electra Therapeutics in?
Electra Therapeutics’s primary industry is Drug Discovery.
-
Is Electra Therapeutics a private or public company?
Electra Therapeutics is a Public company.
-
What is Electra Therapeutics’s stock symbol?
The ticker symbol for Electra Therapeutics is ETRA.
-
What is the current stock price of Electra Therapeutics?
As of 13-Nov-2026 the stock price of Electra Therapeutics is $8.84.
-
What is the current market cap of Electra Therapeutics?
The current market capitalization of Electra Therapeutics is $555M.
-
Who are Electra Therapeutics’s competitors?
Immunocore Holdings, Sorrento Therapeutics, Fate Therapeutics, Exicure, and Lite Strategy are some of the 80 competitors of Electra Therapeutics.
-
What is Electra Therapeutics’s annual earnings per share (EPS)?
Electra Therapeutics’s EPS for 12 months was -$2.65.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
